MDA-MB-231 Breast Cancer Cells Resistant to Pleurocidin-Family Lytic Peptides Are Chemosensitive and Exhibit Reduced Tumor-Forming Capacity
Direct-acting anticancer (DAA) peptides are cytolytic peptides that show promise as novel anticancer agents. DAA peptides bind to anionic molecules that are abundant on cancer cells relative to normal healthy cells, which results in preferential killing of cancer cells. Due to the mechanism by which...
Main Authors: | Ashley L. Hilchie, Erin E. Gill, Melanie R. Power Coombs, Reza Falsafi, Robert E. W. Hancock, David W. Hoskin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/9/1220 |
Similar Items
-
Investigating Potential Applications of the Fish Anti-Microbial Peptide Pleurocidin: A Systematic Review
by: Katelyn A. M. McMillan, et al.
Published: (2021-07-01) -
Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer
by: Olalekan Olanrewaju Bakare, et al.
Published: (2021-07-01) -
Cytotoxic effect of ICD-85 (venom-derived peptides) on MDA-MB-231 cell line
by: A Zare Mirakabadi, et al.
Published: (2008-01-01) -
Studies on the anticancer properties of pleurocidins: a preclinical evaluation
by: Hilchie, Ashley
Published: (2012) -
Antimicrobial Peptides from Fish
by: Jorge A. Masso-Silva, et al.
Published: (2014-03-01)